Sonoma Pharmaceuticals, Inc. (SNOA) Stock Overview
Explore Sonoma Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Sonoma Pharmaceuticals, Inc. (SNOA)
Key Financials
Key Financials
Market Cap
1.9M
P/E Ratio
-0.58
EPS (TTM)
$-0.94
ROE
-0.88%
SNOA Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Sonoma Pharmaceuticals, Inc. (SNOA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 43.38, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.62.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.58 and a market capitalization of 1.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.